Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross …
S Lee, BU Monz, A Clemens, M Brueckmann… - BMJ open, 2012 - bmjopen.bmj.com
Objective Three oral anticoagulants have reported study results for stroke prevention in
patients with atrial fibrillation (AF)(dabigatran etexilate, rivaroxaban and apixaban); all …
patients with atrial fibrillation (AF)(dabigatran etexilate, rivaroxaban and apixaban); all …
[PDF][PDF] Representativeness of the dabigatran, apixaban, and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: A cross …
B Monz, A Clemens, M Brueckmann, G Lip - scienceopen.com
Abstract Word count: 287 words (maximum 300 words) Objective: Three oral anticoagulants
have reported study results for stroke prevention in patients with atrial fibrillation …
have reported study results for stroke prevention in patients with atrial fibrillation …
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross …
S Lee, BU Monz, A Clemens, M Brueckmann… - BMJ …, 2012 - pubmed.ncbi.nlm.nih.gov
Objective Three oral anticoagulants have reported study results for stroke prevention in
patients with atrial fibrillation (AF)(dabigatran etexilate, rivaroxaban and apixaban); all …
patients with atrial fibrillation (AF)(dabigatran etexilate, rivaroxaban and apixaban); all …
[引用][C] Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross …
S Lee, BU Monz, A Clemens, M Brueckmann, GYH Lip - BMJ Open, 2012 - cir.nii.ac.jp
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to
real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the …
real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the …
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross …
S Lee, BU Monz, A Clemens, M Brueckmann, GY Lip - BMJ Open, 2012 - europepmc.org
Objective Three oral anticoagulants have reported study results for stroke prevention in
patients with atrial fibrillation (AF)(dabigatran etexilate, rivaroxaban and apixaban); all …
patients with atrial fibrillation (AF)(dabigatran etexilate, rivaroxaban and apixaban); all …
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross …
S Lee, BU Monz, A Clemens, M Brueckmann… - BMJ …, 2012 - search.proquest.com
Objective Three oral anticoagulants have reported study results for stroke prevention in
patients with atrial fibrillation (AF)(dabigatran etexilate, rivaroxaban and apixaban); all …
patients with atrial fibrillation (AF)(dabigatran etexilate, rivaroxaban and apixaban); all …
[PDF][PDF] Representativeness of the dabigatran, apixaban, and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: A cross …
B Monz, A Clemens, M Brueckmann, G Lip - researchgate.net
Abstract Word count: 287 words (maximum 300 words) Objective: Three oral anticoagulants
have reported study results for stroke prevention in patients with atrial fibrillation …
have reported study results for stroke prevention in patients with atrial fibrillation …
[HTML][HTML] Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a …
S Lee, BU Monz, A Clemens, M Brueckmann, GYH Lip - BMJ Open, 2012 - ncbi.nlm.nih.gov
Objective Three oral anticoagulants have reported study results for stroke prevention in
patients with atrial fibrillation (AF)(dabigatran etexilate, rivaroxaban and apixaban); all …
patients with atrial fibrillation (AF)(dabigatran etexilate, rivaroxaban and apixaban); all …
[PDF][PDF] Sally Lee, Brigitta U Monz, 2 Andreas Clemens, 3 Martina Brueckmann, 3
GYH Lip - trials (RCT) - Citeseer
Objective: Three oral anticoagulants have reported study results for stroke prevention in
patients with atrial fibrillation (AF)(dabigatran etexilate, rivaroxaban and apixaban); all …
patients with atrial fibrillation (AF)(dabigatran etexilate, rivaroxaban and apixaban); all …